Biotech · Private company
Worcester HIV Vaccine
Track this companyFree. Adds Worcester HIV Vaccine to your Dealase workspace and tells you when its record changes.
Clinical trials21 recruiting or active
Pipeline programs7From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline7
- Alhydrogel adjuvantPhase 2 · HIV PreventionClinicalTrials.gov · fetched Nov 12, 2026
- GLA-SE adjuvantPhase 2 · HIV PreventionClinicalTrials.gov · fetched Nov 12, 2026
- PDPHV Plasmid DNA Vaccines (env (A, B, C, A/E)/gag (C))Phase 2 · HIV PreventionClinicalTrials.gov · fetched Nov 12, 2026
- PDPHV Recombinant Protein Vaccines (gp120 (A, B, C, A/E))Phase 2 · HIV PreventionClinicalTrials.gov · fetched Nov 12, 2026
- env (A,B,C,A/E)/gag (C) DNA VaccinePhase 1 · HIV InfectionsClinicalTrials.gov · fetched Nov 12, 2026
- GLA-SE adjuvantPhase 1 · HIV InfectionsClinicalTrials.gov · fetched Nov 12, 2026
- gp120 (A,B,C,A/E) Protein VaccinePhase 1 · HIV InfectionsClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials2
- Evaluating the Safety and Immunogenicity of Polyvalent DNA and Recombinant gp120 Protein HIV Vaccine (PDPHV) in Healthy, HIV-uninfected AdultsPHASE2 · NOT_YET_RECRUITING · started Sep 1, 2026ClinicalTrials.gov NCT07675629 · fetched Nov 12, 2026
- Evaluating the Safety and Immunogenicity of Polyvalent DNA/gp120 HIV Vaccine in Healthy, HIV-uninfected AdultsPHASE1 · COMPLETED · started Jul 8, 2021ClinicalTrials.gov NCT04927585 · fetched Nov 12, 2026